GP73 is a glucogenic hormone that contributes to SARS-CoV-2-induced hyperglycemia
Luming Wan, Hui Zhong(Kunming University of Science and Technology), Huapeng Wang, Yinxin Xu, Lei Xu(Fudan University), Yuehua Ke(Hebei Agricultural University), Xiaopan Yang, Jing Gong(Czech Academy of Sciences, Institute of Biotechnology), Zhiwei Sun, Changjun Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Cheng‐Feng Qin(Academy of Military Medical Sciences), Congwen Wei(Academy of Military Medical Sciences), Yumeng Peng(Academy of Military Medical Sciences), Xiaolin Wang(University of Toronto), Yanhong Zhang(Nanjing Agricultural University), Xiaoli Yang(Guilin Medical University), Changqing Lin, Feixiang Wu(Ministry of Education of the People's Republic of China), Dongyu Li(Wuhan Puai Hospital), Fei Zheng, Qi Gao, Linfei Huang(Academy of Military Medical Sciences), Huilong Li(Fujian Medical University), Huan Yang(BGI Group (China)), Qiulin Yan(Shenyang Pharmaceutical University), Jingfei Li(Academy of Military Medical Sciences), Haotian Lin(Zhejiang University), Yong‐Qiang Deng(Academy of Military Medical Sciences)
Cited by 0
Related Papers
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry
|Nature Metabolism|2020|304
The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein
|The Journal of Immunology|2010|235